title: Evaluation of in vitro cytogenetic techniques in nine European laboratories in relation to chromosomal endpoints induced by three model mutagens.
authors.affiliation: Institute of Occupational Health, Helsinki, Finland.
authors.forename: M
authors.initials: M
authors.lastname: Sorsa
authors.forename: K
authors.initials: K
authors.lastname: Autio
authors.forename: A
authors.initials: A
authors.lastname: Abbondandolo
authors.forename: E
authors.initials: E
authors.lastname: Carbonell
authors.forename: N
authors.initials: N
authors.lastname: Demopoulos
authors.forename: C
authors.initials: C
authors.lastname: Garner
authors.forename: M
authors.initials: M
authors.lastname: Kirsch-Volders
authors.forename: R
authors.initials: R
authors.lastname: Marcos
authors.forename: E
authors.initials: E
authors.lastname: Marafante
authors.forename: A T
authors.initials: AT
authors.lastname: Natarajan
mesh_terms: D001761:Bleomycin / Q000633:toxicity; D002869:Chromosome Aberrations; D002945:Cisplatin / Q000633:toxicity; D005069:Evaluation Studies as Topic; D006801:Humans; D007391:International Cooperation; D008558:Melphalan / Q000633:toxicity; D015162:Micronucleus Tests; D009152:Mutagenicity Tests / Q000379:methods* / Q000592:standards; D009153:Mutagens / Q000633:toxicity; D011786:Quality Control; D012854:Sister Chromatid Exchange
chemical_list: D009153:Mutagens; D001761:Bleomycin; D002945:Cisplatin; D008558:Melphalan